There remain enormous gaps in the information available to the public about the effects of their drugs, and in the application of that information to optimizing prescribing and thereby improving the risk/benefit balance from drugs. Centers for Education and Research on Therapeutics (CERTs) offer the opportunity to address many of these deficits, and this proposal goes a long way toward filling that gap. In particular, we propose to: 1. Establish a CERT with a coordinated infrastructure, including: a. Logistical support, including faculty time and core staff; b. Governance, including regular coordination and business meetings; c. Programmatic coordination, including linkage of the pharmacoepidemiology skills of the Center for Clinical Epidemiology and Biostatistics (CCEB) with the pharmacoeconomics skills of the Leonard Davis Institute of Health Economics, the experience in patient -oriented research of the General Clinical Research Center; basic science laboratories interested in evaluating the molecular mechanisms of drug effects; and the social science skills of non-biomedical researchers in other parts of the University; d. Regularly scheduled educational conference series; e. Active participation in the national network of CERTs; and f. A pilot research grant program targeted at the development of R01 quality grants and proposals. 2. Testing and building the capabilities of the current Penn ambulatory drug use evaluation program as a laboratory, expanding it to broader populations; 3. Improve the use of antibiotics locally and nationally, with studies leading to grant funding for larger scale efforts, as well as formal dissemination of evidence-based data both known and to be known. The initial studies will: a. evaluate techniques to reduce the use of antibiotics for acute bronchitis in the outpatient setting b. evaluate the impact of antimicrobial formulary interventions at different hospitals on the resistance patterns of extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella species; c. simulate data, in order to expand the use of meta-analysis to study rare adverse outcomes from antibiotics; d. study the effects of tetracycline used to treat acne in a dermatology clinic on antibiotic resistance patterns; and e. study the use of the GPRD Database to explore the epidemiology of drug -resistant pneumococcal pneumonia 4. Conduct an extensive education program, including: i) a Masters in Clinical Epidemiology (MSCE) and PhD pharmacoepidemiology fellowship training program; ii) opportunities for MSCE and PhD students in epidemiology and biostatistics to use existing in-house databases to answer new questions, to participate in ongoing research, and to develop new research projects; iii) courses for university physicians housestaff, nurses, and nursing students; iv) courses for pharmacists and pharmacy students; v) courses for medical students; and vi) a degree credit course in pharmacoepidemiology for MSCE students. 5. Organize and formally disseminate the results of our work, consisting of: publications and presentations for the Scientific/Professional community; ii) the FDA, AHCPR, other CERTs, etc.; and iii) the public, building on the dissemination program of the Leonard Davis Institute of Health Economics.

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Demonstration--Cooperative Agreements (U18)
Project #
5U18HS010399-03
Application #
6528433
Study Section
Special Emphasis Panel (ZHS1-SRBB-D (01))
Program Officer
Bosco, Lynn
Project Start
2000-09-01
Project End
2003-09-29
Budget Start
2002-09-01
Budget End
2003-09-29
Support Year
3
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hafkin, J S; Osborn, M K; Localio, A R et al. (2014) Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. J Viral Hepat 21:288-96
Newland, Jason G; Gerber, Jeffrey S; Weissman, Scott J et al. (2014) Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States. Infect Control Hosp Epidemiol 35:265-71
Vinnard, Christopher; Linkin, Darren R; Localio, A Russell et al. (2013) Effectiveness of interventions in reducing antibiotic use for upper respiratory infections in ambulatory care practices. Popul Health Manag 16:22-7
M'ikanatha, Nkuchia M; Dettinger, Lisa A; Perry, Amanda et al. (2012) Culturing stool specimens for Campylobacter spp., Pennsylvania, USA. Emerg Infect Dis 18:484-7
Newman, Ross E; Hedican, Erin B; Herigon, Joshua C et al. (2012) Impact of a guideline on management of children hospitalized with community-acquired pneumonia. Pediatrics 129:e597-604
Forde, K A; Haynes, K; Troxel, A B et al. (2012) Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study. J Viral Hepat 19:271-7
Lo Re 3rd, Vincent; Teal, Valerie; Localio, A Russell et al. (2011) Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study. Ann Intern Med 155:353-60
Strom, Brian L; Schinnar, Rita; Center for Education and Research on Therapeutics, University of Pennsylvania (2011) Evaluating health information technology's clinical effects. LDI Issue Brief 16:1-4
Rattanaumpawan, Pinyo; Tolomeo, Pam; Bilker, Warren B et al. (2011) A clinical prediction rule for fluoroquinolone resistance in healthcare-acquired gram-negative urinary tract infection. Infect Control Hosp Epidemiol 32:1124-6
Haynes, Kevin; Bilker, Warren B; Tenhave, Tom R et al. (2011) Temporal and within practice variability in the health improvement network. Pharmacoepidemiol Drug Saf 20:948-55

Showing the most recent 10 out of 95 publications